Merge, LLC

10/16/2026

Merge Clinical Study Communications excels at media strategy, planning and placement – in traditional media – and in online, mobile and social media – nationally, and globally.

Clinical Study Communications Pardon us as we update, redesign, and improve our website’s efficiency with an advanced new formula.

10/13/2026

Rare disease trials are critical to advancing care, but they face their own unique challenges. This article explores 7 of the most common obstacles & more importantly, offers actionable solutions to overcome them. Read the solution-focused approach here:

Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.

10/01/2026

Is trial recruitment focused on the wrong thing? The biggest challenge isn’t getting patients to participate—it’s getting patients and trials to find each other! Recruiting the right patients starts with connecting them to the right opportunities. Read on:

Under-enrollment isn't news to teams running oncology trials, and the instinct is to spend more on reach. The evidence, however, says the biggest leak is something else entirely and that most recruitment budgets focus on the least valuable part of the problem.

09/28/2026

Merge turns a struggling study into a success with targeted tactics. Read case study.

Clinical Study Communications Pardon us as we update, redesign, and improve our website’s efficiency with an advanced new formula.

09/23/2026

Turning 18 is a major milestone, but it's especially significant if you have a rare disease & participate in trials. As young adults transition from pediatric to adult care, patient support & engagement should evolve, too.

Turning 18 can disrupt care for patients with chronic conditions. Learn how a patient lifecycle strategy helps pharma brands improve adherence, support caregiver transitions, and keep young adults engaged.

09/21/2026

Stimulate stagnant studies. Learn about problem-solving specialties from Merge Clinical Study Communications.

Clinical Study Communications Pardon us as we update, redesign, and improve our website’s efficiency with an advanced new formula.

09/18/2026

Merge Clinical Study Communications is committed to patient research. Looking for a simple, affordable and fast solution? Discover Study Snapshot.

Clinical Study Communications Pardon us as we update, redesign, and improve our website’s efficiency with an advanced new formula.

09/17/2026

calls attention to the importance of clear communication, informed participation, and patient-centered designs in clinical trials and research. When patients are better informed, they’re better equipped to make decisions about their healthcare journey. 🌍🩺🤲

09/15/2026

In February, the FDA announced the shift to a single-trial standard for drug approval, focusing on study quality over quantity and accelerating drug development without lowering standards. Got questions? Applied Clinical Trials Magazine has answers: https://bit.ly/4xo4hAQ

09/09/2026

To maintain subject interest in a two-year Perennial Allergic Rhinitis study, we created a robust subject retention kit to supplement the ongoing recruitment program. Read more.

Clinical Study Communications Pardon us as we update, redesign, and improve our website’s efficiency with an advanced new formula.